Electroporation is seen as an attractive alternative to viral vectors, but users often face a trade-off between transfection efficiency and maintaining cell viability. In addition, electroporation platforms used in process development may be unsuitable for scale-up to manufacturing.
Recognising these challenges, we have developed a solution that draws on TTP’s track record in developing cell processing consumables integrating a custom electronic design.
Our solution addresses the challenges of non-viral transfection methods.
- Unrivalled uniformity in cell processing conditions
- Enhanced cell viability at peak efficiency
- Readily scalable from R&D to manufacturing
To learn more about how our solution has been designed to be “gentle” on cells and how it compares to existing bulk electroporation solutions, please download our technology brochure.
.jpg)
